
05/05/2023
Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer
This editorial describes the science behind a clinical trial performed by Prager and colleagues: a test of trifluridine–tipiracil and bevacizumab to treat patients with refractory metastatic colorectal cancer. https://nej.md/3VnWj8L